Risk of Cervical Precancer and Cancer Among HIV-Infected Women With Normal Cervical Cytology and No Evidence of Oncogenic HPV Infection Cervical Precancer in HIV-Infected Women

ContextUS cervical cancer screening guidelines for human immunodeficiency virus (HIV)–uninfected women 30 years or older have recently been revised, increasing the suggested interval between Papanicolaou (Pap) tests from 3 years to 5 years among th..

Original Article: Risk of Cervical Precancer and Cancer Among HIV-Infected Women With Normal Cervical Cytology and No Evidence of Oncogenic HPV Infection Cervical Precancer in HIV-Infected Women

More From BioPortfolio on "Risk of Cervical Precancer and Cancer Among HIV-Infected Women With Normal Cervical Cytology and No Evidence of Oncogenic HPV Infection Cervical Precancer in HIV-Infected Women"

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications